APR-246
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for APR-246, covering 2020-01-30 to 2025-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/2 Study of APR-246 in Combination With Pembrolizumab in Subjects With Solid Tumor Malignancies [Phase 1, Phase 2]